CGHS pharmacists welfare union demands 20% non-practicing allowance as given to doctors

Citing duties of pharmacists as clinical in nature and post of a pharmacist in a hospital a full time one, the Central Government Health Scheme (CGHS) pharmacists welfare union has urged the Union Health Ministry to pay them 20% of the basic salary as Non-Practicing Allowance (NPA) as is given to the doctors.

In a letter written to the union health secretary, the Chennai branch secretary of the association has stated that as per the Pharmacy Practice Regulations 2015, a clinical pharmacist is eligible to draw non-practicing allowance. Besides, since the pharmacist is posted against a full time post, he is entitled to demand the NPA. Thirdly, as a government employee in whose case there is ample scope for private practice, the pharmacist is eligible to draw the allowance.

The secretary of the union said as per PPR 2015, a pharmacist can do private practice in the way a medical professional does. But he is serving at a post where it is necessary to prohibit private practice in the interest of the public. So, this allowance shall be admissible to him.

Apart from pharmacists, only registered medical practitioners (RMPs) are allowed by government to practice in medical field independently. Pharmacist post fulfills all the requirements to receive the NPA incentive.

In the Regulations published by PCI through government gazette, a registered pharmacist is authorized to practice pharmacy independently. This increases the responsibility of the pharmacists towards their patients and society.

Substantiating their arguments for NPA, the CGHS pharmacists union stated in the letter that the pharmacists were vested with many responsibilities in addition to dispensing drugs. He is a dispensing pharmacist at the pharmacy. At the same time, he undertakes the job of patient counseling also. In hospital he often becomes a clinical pharmacist.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’